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The liver plays a major role in the regulation of glucose ho-
moeostasis. Evidence from liver-specific insulin receptor
knockout mice (LIRKO) suggested that insulin’s direct and
indirect effects on glucoseutilizationby the liver both require
the presence of hepatic insulin receptors (IR). To address this
issue, we have generated immortalized neonatal hepatocytes
bearing (HIR LoxP) or not (HIR KO) IR. The lack of IR sig-
nificantly decreased basal glucose uptake in neonatal hepa-
tocytes from 3- to 14-d-old mice, and the expression of glucose
transporter 1 (GLUT1), GLUT2, and glucokinase (GK) re-
mained unchanged throughout development. HIR KO recon-
stituted hepatocytes with IRA but not with IRB isoform and
restored basal glucose uptake up to the levels observed inHIR
LoxP cells. However, both IR isoforms associatedwithGLUT1
or GLUT2. Overexpression of IGF-I receptor (IGF-IR) in-
creased basal glucose uptake in neonatal hepatocytes lacking
or not IR. This effect was also accompanied by its association
with GLUT1 or GLUT2. Exogenous expression of GLUT4 had
no effect on basal glucose uptake in neonatal hepatocytes.
However, HIR LoxP hepatocytes expressing exogenous
GLUT4 increased glucose uptake in the presence of insulin
without showing association between GLUT4 and IR. Our
data clearly indicate that IR plays a direct role in the regu-
lation of basal glucose uptake/transport by the hepatocytes,
and either type A IR or IGF-IR works on glucose uptake as a
GLUT1- or GLUT2-associated cotransporter. Thus, IR medi-
ates glucose uptake through its specific association with en-
dogenous, but not with exogenous, glucose transporters in
neonatal hepatocytes. (Endocrinology 147: 3709–3718, 2006)
THE LIVER PLAYS a major role in the regulation of glu-cose homoeostasis. Thus, under fasting conditions, he-
patic glucose production (HGP), which represents 90% of
total glucose release, is regulated by insulin by direct and
indirect mechanisms. Conversely, glucose utilization by the
liver is reduced to a minimum (8% of total glucose utiliza-
tion). Deregulation between glucose uptake and production
by the liver is thought to contribute to the onset of type 2
diabetes (1).
The lack of insulin receptor (IR) in a liver-specific manner,
as in liver-specific IR knockout (LIRKO) mice, resulted in an
impaired glucose tolerance, hyperinsulinemia, and hyper-
glycemia related to an increased HGP. Also, LIRKO mice
showed a substantial increase in gluconeogenic gene expres-
sion accompanied by a decrease in glycolytic enzymes such
as glucokinase (GK) or liver pyruvate kinase. The manifest
diabetic phenotype was apparent at 2 months of age. How-
ever, this phenotype was ameliorated throughout 2–6
months, with a normoglycemic metabolism being restored
after 6 months. The regression of glucose intolerance was
paralleled by an increase in glucose consumption by the liver,
likely because of liver dysfunction (2). Euglycemic/hyper-
insulinemic clamps in LIRKO mice showed that insulin did
not suppress HGP as observed in control mice. These data
clearly indicated a severe hepatic insulin resistance in mice
lacking IR in the liver (3). However, restoration of IR in the
liver of LIRKO mice did not rescue insulin’s ability to reduce
glucose production in vivo (4). These results suggest that the
role of hepatic IR and its signaling in the control of HGP in
mice is limited, and consequently, indirect mechanisms of
insulin-mediated inhibition of HGP are dominant (5).
Under postprandial conditions, liver removes 30–40% of
the glucose that enters the portal vein after an oral glucose
load and will replete its glycogen stores (6). Studies have
been performed to define the relationship between insulin
and net hepatic glucose uptake (NHGU) in the face of a 2-fold
increase in the hepatic glucose load and in the presence or
absence of the portal signal (1). There was a relationship
between NHGU and the rate of portal glucose delivery as
indicated by the magnitude of the arterial-portal plasma
glucose gradient in 42-h fasted conscious dogs. NHGU was
augmented by a rise in insulin and further stimulated by the
presence of a portal signal. Thus, NHGU is dependent on the
amount of glucose reaching it, the insulin level within the
hepatic sinusoids, and a signal generated by portal glucose
delivery.
Fed LIRKO mice also showed an impaired insulin toler-
ance and also a postprandial hyperglycemia. Euglycemic/
hyperinsulinemic clamps also revealed a significant decrease
of total glucose utilization in response to insulin in fed
LIRKO mice compared with their controls, an indication of
an insulin-resistance feature. These studies concluded that
insulin’s direct and indirect effects require the presence of
hepatic IR (3). Then, a question arose as to whether or not IR
First Published Online April 27, 2006
Abbreviations: ALB, Albumin; CK18, cytokeratin 18; CPS, carbamoyl
phosphate synthetase; FITC, fluorescein isothiocyanate; FS, fetal serum;
GK, glucokinase; GLUT, glucose transporter; HGP, hepatic glucose pro-
duction; IGF-IR, IGF-I receptor; IR, insulin receptor; IRS-1, insulin re-
ceptor substrate 1; LIRKO, liver-specific insulin receptor knockout;
NHGU, net hepatic glucose uptake; Py, phosphotyrosine; VIM,
vimentin.
Endocrinology is publishedmonthly by The Endocrine Society (http://
www.endo-society.org), the foremost professional society serving the
endocrine community.
0013-7227/06/$15.00/0 Endocrinology 147(8):3709–3718
Printed in U.S.A. Copyright © 2006 by The Endocrine Society
doi: 10.1210/en.2005-1663
3709
might play a direct role in the regulation of glucose uptake/
transport by the liver.
To address this important issue, we have generated im-
mortalized neonatal hepatocytes bearing or not IR. In addi-
tion, we have reconstituted cells with isoforms A (exon 11)
and B (exon 11) of IR because it has been demonstrated that
alternative splicing of IR is developmentally regulated (7).
Our data clearly indicate that IR plays a direct role as glucose
cotransporter in the regulation of glucose uptake/transport
by the hepatocytes, this effect being mediated by its specific




FS and culture media were obtained from Life Technologies, Inc.
(Gaithersburg, MD). Insulin, hygromycin, puromycin, antimouse IgG-
agarose, and monoclonal anti--actin (clone AC-15, no. A5441) antibody
were from Sigma Chemical Co. (St. Louis, MO). The anti-IGF-I receptor
(anti-IGF-IR) -chain (C-20, sc-713), anti-IR -subunit (C-19, sc-711),
anti-glucose transporter 2 (anti-GLUT2) (H-67, sc-9117), and anti-caveo-
lin-1 (sc-894) antibodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA.). The anti-insulin receptor substrate 1 (anti-IRS-1)
(06-248), anti-phosphotyrosine (anti-Py) (clone 4G10, 05-321), and anti-
IRS-2 (06-506) antibodies were purchased from Upstate Biotechnology
(Lake Placid, NY). The anti-GLUT4 (CBL 243) and anti-GLUT1 (CBL 242)
antibodies were from Chemicon International (Temecula, CA). The anti-
phospho-Akt antibody (Ser473 no. 9271) was purchased from Cell Sig-
naling (Beverly, MA). The anti-GK antibody was a gift of J. J. Guinovart
(Barcelona, Spain). For immunofluorescence, fluorescein isothiocyanate
(FITC)-conjugated sheep antimouse Ig and monoclonal antivimentin
(anti-VIM) (cloneV9) antibody were from Roche Molecular Biochemicals
(Mannheim, Germany), polyclonal antialbumin (anti-ALB) antibody
was from Nordic Immunology Laboratories (Tilburg, The Netherlands),
anticytokeratin 18 (anti-CK18) monoclonal antibody (No. 61028) was
from Progen Biotechnik GmbH (Heidelberg, Germany), and monoclonal
anti-carbamoyl phosphate synthetase (anti-CPS) antibody was a gift of
Dr. P. Martı´n-Sanz (Consejo Superior de Investigaciones Cientı´ficas,
Madrid, Spain). Cy3-conjugated goat antirabbit Ig, [-32P]dCTP (3000
Ci/mmol) and 2-deoxy-d[1-3H]glucose (11.0 Ci/mmol) were from Am-
ersham (Aylesbury, UK).
Generation of immortalized HIR LoxP and HIR KO
hepatocyte cell lines
Primary hepatocytes were obtained from livers of 3-, 7-, and 14-d-old
neonatal IR LoxP mice (homozygous for a floxed allele of exon 4 of the
IR) (2) and submitted to collagenase dispersion and primary culture as
previously described (8). Animals were handled in accordance with
approved institutional procedures. Viral Bosc-23 packaging cells were
transfected at 70% confluence by calcium phosphate coprecipitation
with 3g/6-cm dish of the puromycin-resistance retroviral vector pBabe
encoding attenuated simian virus 40 large T antigen (kindly provided
by J. de Caprio, Dana Farber Cancer Institute, Boston, MA). Then, pri-
mary hepatocytes were infected at 60% confluence with polybrene-
supplemented (4 g/ml) virus for 48 h and maintained in culture me-
dium for 72 h before selection with puromycin (1g/ml) for 3 wk. Then,
immortalized cell lines were generated and cultured for 10–15 d with
arginine-free medium supplemented with 10% FS to avoid growth of
nonparenchymal cells. For in vitro recombination of the IR, immortalized
hepatocytes IR LoxP (HIR LoxP), harboring a floxed allele of exon 4 of
the IR, were first cultured to 70–80% confluence. After 24 h, cells were
infected with adenoviruses encoding cre recombinase at a titer of 109
plaque-forming units. After 1 h, growth medium was added for an
additional 48 h. Individual colonies were selected, and deletion of IR was
assessed by Western blot. In addition, these cells (HIR KO) were cloned
twice and resubmitted to viral infection to assure complete IR deletion.
Plasmids and retroviral infection
Coding sequences for the individual spliced isoforms of the human
IR either containing or lacking exon 11 (isoforms B and A, respectively)
and coding sequence for human IGF-IR, cloned into pBABE-hygro ret-
roviral vector, were a gift of C. R. Kahn (Joslin Diabetes Center, Boston,
MA). Viral particles were obtained as described above. HIR KO hepa-
tocytes were infected with polybrene-supplemented (4 g/ml) virus for
48 h and then placed in selection medium containing hygromycin (200
g/ml) for at least 2 wk.
Immunofluorescence and confocal imaging
Cells were grown in glass coverslips until 80% confluence was
reached. Then, cells were washed twice with PBS, fixed in methanol (20
C) for 2 min and processed to immunofluorescence. Primary antibodies
(anti-ALB, anti-CPS, anti-CK18, and anti-VIM) were applied for 1 h at
37 C in PBS/1% BSA, followed by four 5-min washes in PBS, a 45-min
incubation with fluorescence-conjugated antibodies (FITC-conjugated
sheep antimouse and Cy3-conjugated goat antirabbit), and four final
washes of 5 min each in PBS. Immunofluorescence was examined in an
MRC-1024 (Bio-Rad, Hempstead, UK) confocal microscope adapted to
an inverted Nikon Eclipse TE 300 microscope. Images were taken with
488-nm laser excitation for FITC-conjugated antibodies and 514-nm laser
excitation for Cy3-conjugated antibodies. Fluorescence emissions were
detected through a 513/24-nm bandpass filter for FITC and a 605/15-nm
bandpass filter for Cy3.
Immunoprecipitations and Western blot
Quiescent cells (20 h serum-starved) were treated without or with
several doses of insulin and lysed as previously described (9). After
protein content determination, equal amounts of protein (600g to 1 mg)
were immunoprecipitated at 4 C with the corresponding antibodies. The
immune complexes were collected on protein A-agarose or antimouse
IgG-agarose beads and submitted to SDS-PAGE. Proteins were trans-
ferred to Immobilon membranes and incubated overnight with several
antibodies as indicated. Immunoreactive bands were visualized using
the ECL Western blotting protocol (Amersham).
Protein determination
Protein determination was performed by the Bradford dye method
(10), using the Bio-Rad reagent and BSA as the standard.
Transduction of HIR LoxP and HIR KO hepatocytes by
adenoviral infection
Neonatal hepatocytes were infected with adenoviruses encoding
GLUT4 (a generous gift of A. M. Gomez-Foix, University of Barcelona,
Barcelona, Spain) or mock (adenovirus encoding -galactosidase) at a
titer of 109 plaque-forming units. Cells (80–90% confluence) were rou-
tinely infected for 24–48 h as previously described (11).
RNA extraction and Northern blot analysis
At the end of the culture time, total RNA was isolated as described
(12) and submitted to Northern blot analysis. Blots were hybridized with
a probe for GLUT4 or 18S rRNA as a loading control.
Semiquantitative RT-PCR
To analyze endogenous (mouse) and reconstituted (human) IR iso-
forms in immortalized hepatocytes by PCR, 5 g total RNA was primed
with oligodeoxythymidine in the presence of murine mammary tumor
virus reverse transcriptase (Invitrogen, Carlsbad, CA) to synthesize
cDNA. The samples were diluted 5-fold, and 5% of the total volume was
used for subsequent PCR. Primers used were mouse IR exon 11 primer
1, 5-ATCAGAGTGAGTATGACGACTCGG-3, and primer 2, 5-TCCT-
GACTTGTGGGCACAATGGTA-3; and human IR exon 11 primer 1,
5-ACCAGAGTGAGTATGAGGATTCGG-3, and primer 2, 5-TCCG-
GACTCGTGGGCACGCTGGTC-3. PCR were performed as described
(13). Reaction products were resolved on 2% agarose gels.
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Subcellular fractionation
Cells were washed with ice-cold PBS and scraped in homogenization
buffer containing 20 mm Tris-HCl (pH 7.4), 2 mm EGTA, 2 mm EDTA,
1 mm phenylmethylsulfonyl fluoride, 10 mm -mercaptoethanol, 10
g/ml aprotinin, and 10g/ml leupeptin. After 10 min incubation, cells
were homogenized with 30 strokes of a Dounce homogenizer using a
tight-fitting pestle. Nuclei were collected by centrifugation at 500 g for
5 min, and the low-speed supernatant was centrifuged at 100,000 g for
30 min. The high-speed supernatant constituted the cytosolic fraction.
The pellet was washed three times and extracted in ice-cold homoge-
nization buffer containing 1% Triton X-100 for 60 min. The Triton-soluble
component (plasma membrane fraction) was separated from the Triton-
insoluble material (cytoskeletal fraction) by centrifugation at 100,000 
g for 15 min. Plasma membrane and cytosolic fractions were kept at70
C before protein quantification and Western blotting.
Measurement of glucose transport or uptake
Cells were cultured for 20 h in serum-free DMEM (5 mm glucose) and
then treated or not with 10 nm insulin or 10 nm IGF-I for 2 (glucose
transport) or 10 (glucose uptake) minutes. Glucose transport/uptake
was measured by incubating cells with 2-deoxy-d-[1-3H]glucose for 2 or
10 min, respectively, in triplicate dishes from four to six independent
experiments as previously described (14).
Statistical analysis
Statistically significant differences between mean values were deter-
mined using paired Student’s t test.
Results
Generation and characterization of HIR LoxP and HIR KO
immortalized hepatocyte cell lines
Immortalized neonatal hepatocyte cell lines (HIR LoxP)
have been generated from livers of IR loxP mice at 3, 7, and
14 d after birth. All cell lines were obtained after infection of
neonatal hepatocytes in primary culture with retrovirus en-
coding attenuated large T antigen, followed by antibiotic
(puromycin) selection for at least 3 wk. Then, immortalized
cells were cultured for 10–15 d in arginine-free medium
supplemented with epidermal growth factor (20 ng/ml) to
select hepatocytes having a functional urea cycle. Next, we
deleted IR by infection with an adenovirus encoding Cre
recombinase, generating HIR KO cell lines. First, we pro-
ceeded to characterize the phenotype of all these cell lines. A
photograph of growing cells, at different stages of develop-
ment, is shown in Fig. 1A. Then, we performed immunoflu-
orescence of growing cells with a set of antibodies against
metabolic and cytoskeletal markers. Figure 1B shows the
phenotypical characterization of 3-d-old immortalized HIR
LoxP and HIR KO neonatal hepatocytes. HIR LoxP and HIR
KO neonatal hepatocytes express ALB (a plasma protein
secreted exclusively by hepatocytes) as well as CPS (a urea
FIG. 1. Characterization of immortalized hepatocyte cell lines. A, Photograph of growing HIR LoxP and HIR KO neonatal hepatocytes from
3-, 7-, and 14-d-oldmice; B, immunofluorescence detection of ALB, CPS, CK18, and VIM of growingHIR LoxP andHIRKOneonatal hepatocytes
from 3-d-old mice; C, top, cells were grown to confluence in the presence of 10% FS, and whole-cell lysates (100 g of protein) were submitted
to SDS-PAGEandanalyzed byWestern blot (WB) using antibodies against IR-chain, IGF-IR-chain, IRS-1, IRS-2, and p85; bottom, quiescent
HIR LoxP and HIR KO neonatal hepatocytes from 3-d-old mice were stimulated with 10 nM insulin for 5 min. Control cells were cultured in
the absence of the hormone. At the end of the culture time, cells were lysed and 1 mg total protein was immunoprecipitated (IP) with anti-IR
-chain antibody. The resulting immune complexeswere analyzed byWestern blottingwith anti-Py or anti-IR- antibodies. All the results shown
are representative of three experiments.
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cycle marker), indicating that after the immortalization these
cells maintain hepatocyte phenotypic features. Moreover, all
cell lines maintained the expression of the cytoskeletal
marker CK18, indicating the presence of epithelial paren-
chymal cells (15). Conversely, all cell lines showed negative
immunofluorescence with the anti-VIM antibody. VIM is a
cytoskeletal marker characteristic of cells from mesenchymal
origin and should be absent in parenchymal hepatocytes, to
confirm that the maintenance of cell lines in arginine-free
medium has been sufficient to eliminate a possible contam-
ination of fibroblasts in the primary culture.
The deletion of IR was confirmed by Western blot analysis.
As depicted in Fig. 1C, the lack of IR -chain expression was
detected in HIR KO neonatal hepatocytes; meanwhile,
IGF-IR expression remained unchanged in all cell lines at
different stages of development. Also, the postreceptor
downstream insulin signaling machinery, as represented by
IRS-1, IRS-2, and p85, remained unchanged in neonatal
hepatocytes throughout development. Moreover, in HIR KO
cells from 3-d-old mice, no IR -chain tyrosine phosphory-
lation was found after stimulation with 10 nm insulin. Hepa-
tocytes from 7- and 14-d-old mice showed a similar pattern
of cellular and insulin signaling markers (results not shown).
Effect of deletion of IR on glucose transport or uptake in
neonatal hepatocytes
Hepatic glucose uptake and utilization is essential to main-
tain whole-body glucose homeostasis. Accordingly, we next
investigated whether the lack of IR could unbalance the rate
of glucose entry in neonatal hepatocytes. For that goal, HIR
LoxP and HIR KO cells were cultured up to 80% confluence
and then glucose uptake was measured after 20 h of culture
in 5 mm glucose DMEM. The rationale for using 5 mm glu-
cose was to simulate its physiological relevance at the portal
vein from suckling animals. As shown in Fig. 2A, the lack of
IR decreased by 50% basal glucose uptake in neonatal hepa-
tocytes from 3-d-old mice. Also, a 30% decrease in cells from
7- and 14-d-old mice was observed, as compared with their
corresponding HIR LoxP controls. Interestingly, basal glu-
cose uptake decreased significantly in HIR LoxP neonatal
hepatocytes from 7- and 14-d-old mice, compared with HIR
LoxP cells from 3-d-old mice. Although IR mRNA was still
present in KO cells, because deletion of exon 4 by cre re-
combination creates a frameshift mutation predicting a pre-
mature stop codon, the ratio of IRA to IRB isoforms did not
change among the several HIR LoxP mouse hepatocyte cell
lines from different stages of development, as revealed by
semiquantitative PCR (Fig. 2A, right inset). Importantly, HIR
LoxP neonatal hepatocytes showed a similar profile of IRA
and IRB isoforms to that of wild-type immortalized neonatal
hepatocytes. As expected, glucose uptake in neonatal hepa-
tocytes was insulin independent (Fig. 2B). To investigate
whether the lack of IR in hepatocytes could differentially
affect glucose transport and/or glucose uptake, HIR LoxP
and HIR KO cells were incubated with [3H]2-deoxyglucose
for 2 or 10 min, respectively. The results depicted in Fig. 2C
indicated that the lack of IR equally down-regulates glucose
uptake (10 min) or transport (2 min) in hepatocytes. More-
over, the ubiquitously expressed GLUT1, the liver-specific
GLUT2, and GK expression remained unchanged in all cell
lines bearing or not IR. In addition, the expression of glucose
6-phosphatase was very modest in neonatal hepatocytes un-
der the experimental conditions herein described (results not
shown). All these data reinforce the notion that glucose up-
take is much affected by the lack of IR in neonatal hepato-
cytes but not by a dysregulation in glucose phosphorylation/
dephosphorylation.
Differential restoration of basal glucose uptake by
reconstitution with IRA and IRB isoforms in HIR KO
neonatal hepatocytes
To determine whether or not IR splice isoforms have a
unique role in glucose uptake in hepatocytes, HIR KO cells
were infected with retroviruses encoding for human IRA or
IRB. A representative Western blot of the levels of IR expres-
sion in reconstituted cells is shown (Fig. 3A, left). Moreover,
specific reconstitution with IRA or IRB isoforms was assessed
by PCR (Fig. 3A, right). To assess the functionality of recon-
stituted insulin receptors, we analyzed the response of re-
constituted hepatocyte cell lines to insulin in inducing ty-
rosine phosphorylation of IR. Quiescent cells were
stimulated with 10 nm insulin for 5 min and then lysed. Equal
amounts of protein (1 mg) were immunoprecipitated with
the anti-IR -chain antibody, and tyrosine phosphorylation
of IR was analyzed by anti-Py Western blot. As shown in Fig.
3B (left), insulin was able to stimulate tyrosine phosphory-
lation of IR in HIR KO reconstituted hepatocytes with both
splice isoforms of IR (IRA and IRB) to the same extent as in
HIR LoxP hepatocytes. As expected, no effect of insulin was
observed on tyrosine phosphorylation of IR in HIR KO hepa-
tocytes. In addition, reconstitution of HIR KO hepatocytes
with either IRA or IRB rescued Akt phosphorylation in re-
sponse to insulin. These data clearly indicate that both iso-
forms of IR were functional in reconstituted neonatal
hepatocytes.
The glucose transporter GLUT2 is a transmembrane pro-
tein that facilitates the net hepatic efflux of glucose. The
coimmunoprecipitation of IR and GLUT2 in rat hepatocytes
has recently been demonstrated (16). Here, we studied
whether this association occurs in HIR LoxP or HIR KO
reconstituted hepatocytes with IRA or IRB isoforms, respec-
tively. As a negative control, we used HIR KO hepatocytes.
Cell lysates were obtained from the corresponding hepato-
cyte cell lines, and 1 mg total protein was immunoprecipi-
tated with anti-GLUT2 antibody. The resulting immune com-
plexes were analyzed by Western blot with the anti-IR
-chain antibody. The coimmunoprecipitation IR/GLUT2
band was observed in HIR LoxP and HIR KO reconstituted
hepatocytes with IRA and IRB isoforms, respectively, but not
in HIR KO cells (Fig. 3B, right). To analyze whether this
coimmunoprecipitation could also involve the ubiquitously
expressed GLUT1, we performed the same experiment by
immunoprecipitating whole-cell lysates with the anti-
GLUT1 antibody. As depicted in Fig. 3B (right), we also
observed GLUT1/IRA and GLUT1/IRB immune complexes
in neonatal hepatocytes.
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Our next goal was to investigate whether there were dif-
ferences in the subcellular localization of IR isoforms with
glucose transporters. Accordingly, we performed a subcel-
lular fractionation protocol to separate plasma membrane
and cytosolic fractions from HIR KO hepatocytes reconsti-
tuted with IRA or IRB isoforms as well as from HIR LoxP and
HIR KO cells as controls. Then, equals amount of protein
from each fraction were immunoprecipitated with anti-
GLUT2 antibody and subsequently analyzed by Western blot
with the anti-IR -chain antibody. Figure 3B (right) reveals
that no differences were observed in the association IRA or
IRB isoforms with GLUT2, with the protein band being vi-
sualized in the plasma membrane fraction but not in the
cytosol.
To assess that IR plays a direct role in glucose uptake, we
investigated whether reconstituted HIR KO hepatocytes
with IRA and IRB isoforms were able to restore basal glucose
uptake. As depicted in Fig. 3C, HIR KO reconstituted hepa-
tocytes with IRA isoform restored basal glucose uptake up to
the levels observed in HIR LoxP cells. However, no effect was
observed in reconstituted hepatocytes with the IRB isoform.
Overexpression of IGF-IR increases basal glucose uptake in
HIR LoxP and HIR KO hepatocytes
IR and IGF-IR are highly homologous tyrosine kinase re-
ceptors and activate many of the same signaling cascades in
target cells. In fact, IGF-I activates glucose uptake in insulin-
sensitive cells such as brown adipocytes (17). Accordingly,
FIG. 2. Effect of IR deletion on basal glucose uptake or transport in neonatal hepatocytes. A, Left, Immortalized HIR LoxP neonatal hepatocytes
obtained from 3-, 7-, and 14-d-old mice were cultured to 80% confluence and then serum-starved in 5 mM DMEM for 15 h. Glucose uptake was
measured as described in Materials and Methods. Results are expressed as cpm/g total protein and are means  SE from three independent
experiments with duplicate dishes. Statistical significance was carried out by Student’s t test by comparison of HIR KO with HIR LoxP cells
from 3-, 7-, and 14-d-old mice, respectively (*, P  0.05) or HIR LoxP cells from 7- and 14-d-old mice vs. HIR LoxP cells from 3-d-old mice (,
P 0.05). Inset, Total RNA was isolated from HIR LoxP (from 3-, 7-, and 14-d-old mice), HIR KO (from 3-d-old mice), and wild-type (WT) (from
3-d-old mice) neonatal hepatocytes, and RT-PCR was performed as described inMaterials and Methods. A representative experiment is shown.
B, Hepatocytes were serum starved for 12–15 h in 5mM glucose DMEM and stimulated with 10 nm insulin (Ins). Glucose uptake was measured,
and results are expressed as cpm/g total protein and are means  SE from three independent experiments with duplicate dishes. C, Top, HIR
LoxP and HIR KO cells were incubated with a mix of [3H]glucose and cold glucose for 2 or 10 min. Glucose transport/uptake was measured,
and results are expressed as cpm/g total protein and are means  SE from three independent experiments with duplicate dishes. Statistical
significancewas carried out by Student’s t test by comparison ofHIRKOwithHIRLoxP cells (*,P 0.05).Bottom, Cellswere grown to confluence
in the presence of 10%FS.Whole-cell lysates (100g protein) were submitted to SDS-PAGEand analyzed byWestern blot (WB) using antibodies
against GLUT1, GLUT2, GK, and -actin. A representative experiment of three is shown.
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our next purpose was to investigate whether overexpression
of IGF-IR could compensate for the decrease in basal glucose
uptake observed in HIR KO neonatal hepatocytes lacking IR.
Thus, we overexpressed IGF-IR in both HIR LoxP and HIR
KO cells by means of retroviral infection, generating HIR
LoxP (IGF-IR) and HIR KO (IGF-IR) hepatocyte cell lines,
respectively. Neonatal hepatocytes lacking or not IR ex-
pressed similar levels of IGF-IR. After retroviral infection,
IGF-IR expression was increased by 2-fold in both cell lines
(Fig. 4A, top). Then, we performed anti-IGF-IR Western blot
from anti-GLUT2 or anti-GLUT1 immunoprecipitates. As
shown in Fig. 4A (bottom), IGF-IR coimmunoprecipitated
with GLUT2 or GLUT1 in neonatal hepatocytes. These re-
sults indicate that besides IR/GLUT2 or IR/GLUT1 complex
formation, IGF-IR can also associate with either GLUT1 or
GLUT2 independently of IR. Then, we measured basal glu-
cose uptake in HIR LoxP (IGF-IR) and HIR KO (IGF-IR) cells.
As shown in Fig. 4B, overexpression of IGF-IR increased
basal glucose uptake in neonatal hepatocytes regardless
of IR.
FIG. 3. Differential restoration of basal glucose uptake by reconstitution of IRA and IRB isoforms in HIR KO neonatal hepatocytes. A, Left, HIR
KOhepatocyteswere infectedwith a retroviral vector encoding IRA or IRB isoforms.Hygromycin-resistant cloneswere expanded, and cell lysates
were analyzed by Western blot (WB) with anti-IR -chain antibody. Right, Reconstitution of HIR KO hepatocytes with IRA or IRB isoforms was
analyzed by RT-PCR as described inMaterials and Methods. B, Left, Quiescent (20-h serum-starved) hepatocytes were stimulated with insulin
(10 nM) for 5 min. Control cells were cultured in the absence of the hormone. At the end of the culture time, cells were lysed, and 1 mg total
protein was immunoprecipitated (IP) with anti-IR- chain antibody. The resulting immune complexes were analyzed by Western blotting (WB)
with anti-Py or anti-IR -chain antibodies, as indicated in each panel. Phosphorylation of Akt was measured by Western blot with the
anti-phospho-Akt (ser473) antibody. The results shown are representative of three experiments. Right, HIR LoxP, HIR KO, and reconstituted
cells HIR KO Re-A and HIR KO Re-B neonatal hepatocytes were lysed, and 1 mg of total protein was immunoprecipitated with anti-GLUT2
or anti-GLUT1 antibodies. The resulting immune complexes were analyzed by Western blotting with anti-IR -chain antibody, as indicated
in each panel. A representative experiment of three is shown. Cells were collected for subcellular fractionation. Equals amount of protein from
plasma membrane and cytosolic fractions were immunoprecipitated with the anti-GLUT2 antibody and analyzed by Western blot with the
anti-IR -chain antibody. The experiment was repeated three times with similar results. C, HIR LoxP, HIR KO, and reconstituted cells (HIR
KO Re-A and HIR KO Re-B) were serum starved for 12–15 h in 5 mM glucose DMEM. Glucose uptake was measured, and results are expressed
as cpm/g total protein and are means SE from three independent experiments with duplicate dishes. Statistical significance was carried out
by Student’s t test by comparison of HIR KO Re-A and HIR KO Re-B cells vs. HIR KO. *, P  0.05.
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Exogenous expression of GLUT4 drives insulin and
IGF-I-induced glucose uptake in HIR LoxP and HIR
KO, respectively
Insulin stimulates glucose uptake in muscle and adipose
tissues through translocation of GLUT4 from an intracellular
pool into the plasma membrane (18). Because liver lacks
GLUT4, our next aim was to investigate whether or not IR
could associate with exogenously expressed GLUT4. For that
goal, HIR LoxP and HIR KO hepatocytes were infected with
adenoviruses encoding GLUT4 or empty vector (mock). As
shown in Fig. 5A, both cell lines transduced with GLUT4
adenoviruses expressed GLUT4 mRNA, as revealed by a
representative Northern blot analysis. More importantly,
GLUT4 protein expression was detected in HIR LoxP and
HIR KO neonatal hepatocytes transduced with GLUT4 ad-
enoviruses but not with mock adenoviruses. Then, we stud-
ied whether the association of IR/GLUT4 or IGF-IR/GLUT4
occurs in HIR LoxP or HIR KO, respectively, under basal
conditions or upon insulin/IGF-I stimulation. Neonatal
hepatocytes were transduced with GLUT4 or mock adeno-
viruses for 48 h. Then, HIR LoxP and HIR KO cells were
stimulated with 10 nm insulin or 10 nm IGF-I, respectively.
Whole-cell lysates were immunoprecipitated with anti-
GLUT4 antibody, and the resulting immune complexes were
analyzed by Western blot with the anti-IR -chain (HIR LoxP
cells) or anti-IGF-IR -chain (HIR KO cells) antibodies. As
shown in Fig. 5A (bottom), IR/GLUT4 or IGF-IR/GLUT4
coimmunoprecipitates were not observed regardless of in-
sulin or IGF-I stimulation in the corresponding cells.
To assess whether the lack of association between exog-
enously expressed GLUT4 and IR or GLUT4 and IGF-IR may
be accounted for by a distinctive cellular compartmentation,
we studied GLUT4 protein subcellular localization in trans-
duced hepatocytes under basal conditions and upon insulin
or IGF-I stimulation. Cells were serum starved for 12–15 h
and stimulated with 10 nm insulin (HIR LoxP cells) or 10 nm
IGF-I (HIR KO cells) for 15 min, respectively. Then, we per-
formed a subcellular fractionation protocol to separate
plasma membrane and cytosolic fractions of GLUT4-positive
hepatocytes. As shown in Fig. 5B, a GLUT4 protein band was
visualized only in the plasma membrane fraction in either
nonstimulated or stimulated cells. Finally, we investigated
whether GLUT4-expressing hepatocytes were able to in-
crease glucose uptake in response to insulin or IGF-I. For that
goal, HIR LoxP and HIR KO neonatal hepatocytes were
transduced with adenoviruses encoding GLUT4 or mock
adenoviruses. Forty-eight hours later, cells were serum
starved in 5 mm glucose DMEM for 12–15 h and stimulated
for 20 min with 10 nm insulin (HIR LoxP) or 10 nm IGF-I (HIR
KO), respectively. As depicted in Fig. 5C, transduction with
GLUT4 adenovirus did not affect basal glucose uptake in
both cell types. However, insulin and IGF-I treatment sig-
nificantly increased glucose uptake in HIR LoxP and HIR
KO, respectively.
Discussion
The liver plays a major role in insulin-regulated glucose
homoeostasis through the balance between glucose utiliza-
tion and glucose production, both processes being tightly
coordinated. However, whereas the direct and/or indirect
effects of insulin on HGP are widely recognized, uncertainty
remains regarding its direct or indirect role in glucose dis-
posal by the liver (1).
Euglycemic/hyperinsulinemic clamp studies in LIRKO
mice showed a severe insulin resistance either in total glu-
cose utilization or HGP. Thus, the lack of IR and its signaling
break down the balance between glucose utilization and
glucose production by the liver. The final outcome was a
diabetic phenotype showing a severe compensatory hyper-
insulinemia, accompanied by postprandial and fasting hy-
perglycemia (2). These data strongly suggest that IR by itself
is involved in both glucose disposal and glucose output by
the liver. On the other hand, liver-specific phosphoinositide-
dependent protein kinase 1 knockout mice just recently
showed an impaired glucose tolerance, but insulin tolerance.
Thus, the defect in insulin signaling impaired the inhibition
of gluconeogenic enzymes and glucose output in response to
FIG. 4. Overexpression of IGF-IR increases basal glucose uptake in
HIR LoxP and HIR KO neonatal hepatocytes. A, Top, HIR KO hepa-
tocytes were infected with a retroviral vector encoding IGF-IR. Hy-
gromycin-resistant clones were expanded, and cell lysates were an-
alyzed by Western blot (WB) with anti-IGF-IR -chain antibody.
Bottom, Cells were lysed, and 1 mg total protein was immunopre-
cipitated (IP) with anti-GLUT1 or anti-GLUT2 antibodies. The re-
sulting immune complexes were analyzed by Western blotting with
anti-IGF-IR -chain antibody, as indicated in each panel. The results
shown are representative of three experiments. B, HIR LoxP, HIR
LoxP (IGF-IR), HIR KO, and HIR KO (IGF-IR) hepatocytes were
serum starved for 12–15 h in 5 mM glucose DMEM. Glucose uptake
was measured, and results are expressed as cpm/g total protein and
are means  SE from three independent experiments with duplicate
dishes. Statistical significance was carried out by Student’s t test by
comparison of HIR LoxP (IGF-IR) and HIR KO (IGF-IR) cells vs.HIR
LoxP and HIR KO, respectively. *, P  0.05.
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insulin by the liver without insulin resistance. Accordingly,
these mice show normal insulinemia or postprandial/fasting
glycemia (19). Taken together, these results seem to suggest
that IR rather than insulin signaling regulates glucose dis-
posal by the liver. However, deletion of IR in the liver greatly
affects GK protein content, whose gene expression requires
insulin signaling (2). Therefore, a direct role of insulin sig-
naling in the basal glucose transport/uptake by the liver
cannot be ruled out.
Our results provide strong evidence regarding the direct
role of IR in controlling glucose uptake by the hepatocytes.
More importantly, the decrease in basal glucose uptake/
transport in neonatal hepatocytes occurred without changes
in the expression of GLUT1, GLUT2, and GK. In fact, glucose
metabolism is required for regulation of GLUT2 expression
in the liver in vivo and in vitro (20). In addition, neonatal
hepatocytes virtually lack the expression of gluconeogenic
enzymes such as glucose 6-phosphatase under the experi-
mental conditions assayed. These results point out that glu-
cose transport/uptake rather than glucose phosphorylation/
dephosphorylation is compromised by the lack of IR in
neonatal hepatocytes. On the other hand, this effect was
observed in a postnatal development-dependent manner.
However, the decrease in basal glucose uptake observed in
3-d-old neonatal hepatocytes lacking IR was less prominent
in cells from 7- and 14-d-old mice. In fact, suckling newborns
show a marked hypoinsulinemia and, consequently, very
limited insulin-induced glucose consumption by extrahe-
patic tissues. Whether the functional impact of the IR re-
garding glucose uptake can be extrapolated to adult hepa-
tocytes remains to be established.
Reconstitution of HIR KO cells with insulin receptor A
isoform (Ex11) (IRA) restored basal glucose uptake up to
the levels observed in wild-type hepatocytes. Conversely,
reconstitution with insulin receptor B isoform (Ex11) (IRB)
had no effect on glucose uptake. However, both IR isoforms
associate with GLUT1 or GLUT2 in the absence of insulin
signaling. Thus, our results show IR/GLUT1 or IR/GLUT2
FIG. 5. Exogenous expression of GLUT4 drives an insulin- and IGF-I-induced glucose uptake in HIR LoxP and HIR KO neonatal hepatocytes,
respectively. A, Top, HIR LoxP and HIR KO neonatal hepatocytes were infected with adenoviruses encoding mock and GLUT4, and 48 h after
infection, GLUT4 mRNA level was analyzed by Northern blot. A representative experiment is shown. Bottom, At 48 h after transduction, cells
were stimulated with 10 nM insulin (HIR LoxP) or 10 nm IGF-I (HIR KO) for 15 min. Cells were lysed, and GLUT4 protein content was analyzed
by Western blot (WB). Total protein (1 mg) was immunoprecipitated (IP) with anti-GLUT4 antibody. The resulting immune complexes were
analyzed by Western blotting with anti-IR- (	
 LoxP) or anti-IGF-IR- (HIR KO) antibodies, as indicated in each panel. The results shown
are representative of three experiments. B, At 48 h after transduction, cells were stimulated with 10 nM insulin (HIR LoxP) or 10 nm IGF-I
(HIR KO) for 15 min and collected for subcellular fractionation. Ten micrograms of plasma membrane and cytosolic proteins of each condition
were subjected to SDS-PAGE and analyzed by Western blot with the anti-GLUT4 and anti-caveolin-1 antibodies. A representative experiment
is shown. C, Cells were cultured as described in B. Glucose uptake was measured, and results are expressed as cpm/g total protein and are
means SE from three independent experiments with duplicate dishes. Statistical significance was carried out by Student’s t test by comparison
of insulin-stimulated HIR LoxP (GLUT4) and IGF-I-stimulated HIR KO (GLUT4) cells vs. nonstimulated cells. *, P  0.05.
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complexes as recently reported for GLUT2 in rat hepatocytes
(16). However, no involvement of GLUT2/IR association or
of GLUT1/IR was made on basal hepatic glucose uptake in
rat hepatocytes. Now, our data clearly suggest a direct role
of IR in the molecular mechanism of hepatic glucose uptake
independently of insulin action. Regarding selectivity of IR
isoforms in the restoration of hepatic glucose uptake, both
receptors have been related to differential insulin signaling
in -cells. Whereas isoform A is involved in insulin signaling
leading to insulin gene transcription, isoform B signals
through Akt leading to GK gene expression (21). In our
hands, both IRA and IRB reconstituted hepatocytes signal
through Akt. Thus, selectivity of IR isoforms in the restora-
tion of hepatic glucose uptake because of differential signal-
ing through Akt can be ruled out. Furthermore, our data on
semiquantitative PCR show a very similar IRA/IRB ratio in
neonatal hepatocytes. These results strongly suggest that
isoform A predominates over isoform B of the IR in the
regulation of glucose uptake by neonatal hepatocytes.
Whether a shift in the IRA/IRB ratio may contribute to di-
minished IR-mediated glucose consumption by adult hepa-
tocytes remains to be established.
Overexpression of IGF-IR increased glucose uptake in neo-
natal hepatocytes in the presence or absence of IR. Also,
IGF-IR associated with GLUT1 or GLUT2 regardless of IR.
These data also suggest a molecular mechanism of hepatic
glucose uptake independently of insulin action. Taken to-
gether, our data suggest that either IRA or IGF-IR works as
GLUT1- or GLUT2-associated glucose cotransporter in neo-
natal hepatocytes. These results could shed some light on the
diabetic phenotype regression that occurred at 4–6 months
in LIRKO mice. At that time, LIRKO mice are normoglycemic
and develop a liver dysfunction related to the occurrence of
hyperplastic nodules. Thus, the lack of IR could be compen-
sated by overexpression of IGF-IR, which in fact would en-
hance glucose uptake by the liver.
Exogenous expression of GLUT4 had no effect on basal
glucose uptake in neonatal hepatocytes lacking or not IR,
GLUT4 being mostly localized at the plasma membrane.
Moreover, no association between GLUT4 and the IR was
observed in GLUT4-expressing neonatal hepatocytes bearing
or not IR. Although the GLUT family shows a high level of
sequence homology and predicted secondary structure
similarity, they show a differential targeting in polarized
epithelial cells. Whereas GLUT1 and GLUT2 were predom-
inantly targeted to the basolateral domain of the cells, insu-
lin-regulatable GLUT4 was found in intracellular tubulove-
sicular structures beneath the surface of the cell (22). This
differential localization might explain the lack of interaction
of IR and GLUT4. However, hepatocytes expressing GLUT4
increased glucose uptake in response to insulin or IGF-I, this
effect being independent of GLUT4 translocation into the
plasma membrane. These data suggest a differentiation be-
tween GLUT4 translocation and its intrinsic activation in the
insulin-induced glucose uptake, as previously suggested in
muscle and adipose cells (23). In fact, mouse liver expresses
most of the GLUT4-trafficking protein machinery, but not
Vamp (vesicle-associated membrane protein) 2 (24, 25). More
importantly, the effect of insulin on glucose uptake occurred
without showing any association between GLUT4 and IR.
Thus, IR works on glucose uptake through its specific asso-
ciation with endogenous, but not with exogenous, glucose
transporters in neonatal hepatocytes.
In conclusion, type A, but not type B, IR plays a direct role
in the regulation of glucose uptake/transport in neonatal
hepatocytes. This effect is independent of insulin. Also,
IGF-IR positively regulates glucose uptake by neonatal hepa-
tocytes, regardless of IR. Thus, either type A IR or IGF-IR
works on glucose uptake as a GLUT-1- or GLUT2-associated
cotransporter. Exogenous expression of GLUT4 localizes into
the plasma membrane, although GLUT4 does not increase
basal glucose uptake in neonatal hepatocytes lacking or not
IR. Hepatocytes expressing exogenous GLUT4 increase glu-
cose uptake in the presence of insulin, without showing
association between GLUT4 and IR. These results suggest
that IR regulates glucose uptake as cotransporter through its
specific association with endogenous, but not exogenous,
glucose transporters in neonatal hepatocytes.
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